NO944914L - Fremgangsmåte for å inhibere autoimmunsykdommer - Google Patents
Fremgangsmåte for å inhibere autoimmunsykdommerInfo
- Publication number
- NO944914L NO944914L NO944914A NO944914A NO944914L NO 944914 L NO944914 L NO 944914L NO 944914 A NO944914 A NO 944914A NO 944914 A NO944914 A NO 944914A NO 944914 L NO944914 L NO 944914L
- Authority
- NO
- Norway
- Prior art keywords
- autoimmune diseases
- inhibiting autoimmune
- inhibiting
- hexamethyleneamino
- och2ch2
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/170,608 US5521198A (en) | 1993-12-21 | 1993-12-21 | Methods of inhibiting autoimmune diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO944914D0 NO944914D0 (no) | 1994-12-19 |
| NO944914L true NO944914L (no) | 1995-06-22 |
Family
ID=22620579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944914A NO944914L (no) | 1993-12-21 | 1994-12-19 | Fremgangsmåte for å inhibere autoimmunsykdommer |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US5521198A (ja) |
| EP (1) | EP0664123A1 (ja) |
| JP (1) | JPH07215855A (ja) |
| KR (1) | KR950016723A (ja) |
| CN (1) | CN1108102A (ja) |
| AU (1) | AU699255B2 (ja) |
| CA (1) | CA2138509A1 (ja) |
| CZ (1) | CZ320694A3 (ja) |
| HU (1) | HUT71327A (ja) |
| IL (1) | IL112031A (ja) |
| NO (1) | NO944914L (ja) |
| NZ (1) | NZ270164A (ja) |
| PH (1) | PH31599A (ja) |
| RU (1) | RU94044454A (ja) |
| ZA (1) | ZA9410083B (ja) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| US5434166A (en) * | 1994-08-22 | 1995-07-18 | Eli Lilly And Company | Methods of inhibiting demyelinating and desmyelinating diseases |
| US5545641A (en) * | 1994-10-20 | 1996-08-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of bradykinin |
| HUP9801829A3 (en) * | 1995-02-06 | 1999-10-28 | Lilly Co Eli | Use of benzotiophene derivatives for producing pharmaceutical compositions for inhibiting effects of il-6 |
| CA2223595C (en) * | 1995-06-07 | 2008-08-05 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| US5985932A (en) * | 1996-02-28 | 1999-11-16 | Pfizer Inc | Inhibition of autoimmune diseases |
| IL120266A (en) * | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
| US6117911A (en) * | 1997-04-11 | 2000-09-12 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| US6008232A (en) * | 1997-08-20 | 1999-12-28 | Eli Lilly And Company | Methods for preventing headaches |
| US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| AU3910700A (en) | 1999-03-22 | 2000-10-09 | Immugen Pharmaceuticals, Inc. | Treatment of immune diseases |
| CN1250563C (zh) | 1999-05-04 | 2006-04-12 | 斯特拉坎有限公司 | 雄激素糖苷及其产生雄性征的活性 |
| US6541510B2 (en) * | 2000-09-28 | 2003-04-01 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
| WO2002026224A2 (en) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| US6613083B2 (en) | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
| WO2003080043A1 (en) * | 2002-03-18 | 2003-10-02 | Immugen Pharmaceuticals, Inc. | Topical formulations of resorcinols and cannibinoids and methods of use |
| JP3887588B2 (ja) * | 2002-08-30 | 2007-02-28 | 株式会社リガク | Ｘ線回折による応力測定法 |
| JP2006515616A (ja) * | 2003-01-06 | 2006-06-01 | ワイス | 多発性硬化症の治療のためのエストロゲン受容体αモジュレーターの使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| DK0667768T3 (da) * | 1992-10-27 | 1999-09-27 | Orion Yhtymae Oy | Anvendelse af toremifen til behandling af SLE |
| JP4111352B2 (ja) | 1996-05-21 | 2008-07-02 | 新日鐵住金ステンレス株式会社 | ステンレス鋼の高清浄化精錬法 |
-
1993
- 1993-12-21 US US08/170,608 patent/US5521198A/en not_active Expired - Fee Related
-
1994
- 1994-12-19 PH PH49582A patent/PH31599A/en unknown
- 1994-12-19 HU HU9403658A patent/HUT71327A/hu unknown
- 1994-12-19 KR KR1019940034914A patent/KR950016723A/ko not_active Withdrawn
- 1994-12-19 CA CA002138509A patent/CA2138509A1/en not_active Abandoned
- 1994-12-19 IL IL11203194A patent/IL112031A/xx not_active IP Right Cessation
- 1994-12-19 NO NO944914A patent/NO944914L/no unknown
- 1994-12-19 NZ NZ270164A patent/NZ270164A/xx unknown
- 1994-12-19 EP EP94309465A patent/EP0664123A1/en not_active Withdrawn
- 1994-12-19 AU AU81537/94A patent/AU699255B2/en not_active Ceased
- 1994-12-19 ZA ZA9410083A patent/ZA9410083B/xx unknown
- 1994-12-19 CZ CZ943206A patent/CZ320694A3/cs unknown
- 1994-12-19 CN CN94119736A patent/CN1108102A/zh active Pending
- 1994-12-19 RU RU94044454/14A patent/RU94044454A/ru unknown
- 1994-12-19 JP JP6314597A patent/JPH07215855A/ja active Pending
-
1995
- 1995-05-19 US US08/445,435 patent/US6436958B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU8153794A (en) | 1995-06-29 |
| IL112031A (en) | 1999-12-22 |
| PH31599A (en) | 1998-11-03 |
| HU9403658D0 (en) | 1995-02-28 |
| KR950016723A (ko) | 1995-07-20 |
| NZ270164A (en) | 1997-08-22 |
| NO944914D0 (no) | 1994-12-19 |
| JPH07215855A (ja) | 1995-08-15 |
| CZ320694A3 (en) | 1995-09-13 |
| US6436958B1 (en) | 2002-08-20 |
| AU699255B2 (en) | 1998-11-26 |
| EP0664123A1 (en) | 1995-07-26 |
| ZA9410083B (en) | 1996-06-19 |
| US5521198A (en) | 1996-05-28 |
| CN1108102A (zh) | 1995-09-13 |
| IL112031A0 (en) | 1995-03-15 |
| CA2138509A1 (en) | 1995-06-22 |
| HUT71327A (en) | 1995-11-28 |
| RU94044454A (ru) | 1996-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944914L (no) | Fremgangsmåte for å inhibere autoimmunsykdommer | |
| NO944919L (no) | Fremgangsmåte for å inhibere atrofi av huden eller vagina | |
| NO944928L (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
| NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
| NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
| MY132056A (en) | Methods of inhibiting physiological conditions associated with an excess of neuropeptide y. | |
| NO944930L (no) | Hemming av dysfunksjonell uterin blödning | |
| DK0652005T3 (da) | Fremgangsmåder til inhibering af endometriose | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| NO944926L (no) | Fremgangsmåter for å inhibere myeloperoksidaseaktivitet | |
| DK0651999T3 (da) | Fremgangsmåder til inhibering af livmoderfibrose | |
| NO944934L (no) | Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom | |
| MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
| UA32427C2 (uk) | Застосування бензотіофенів або їх фармацевтично прийнятних солей або сольватів для інгібування ангіогенезу і/або ангіогенних захворювань | |
| NO944924L (no) | Fremgangsmåter for inhibering av Turner's syndrom | |
| NO944931L (no) | Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet | |
| NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
| NO944923L (no) | Hemming av vektökning eller indusering av vekttap | |
| NO973367L (no) | Fremgangsmåte for å inhibere miljömessige östrogen | |
| NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
| NO944909L (no) | Fremgangsmåter for inhibering av mannlig infertilitet | |
| NO944910L (no) | Fremgangsmåte for å inhibere obsessive-kompulsive tilstander og spiseforstyrrelser | |
| NO944577L (no) | Hemming av effekten av amyloidogene proteiner | |
| NO944912L (no) | Fremgangsmåte for å öke makrofagfunksjonen | |
| NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin |